Episode 17: Challenges of developing DMOADs
Prof. Ali Mobasheri identifies the key issues in developing a successful DMOAD and how they can be overcome.
Medicine Matters: The Springer Medicine Podcast
Medicine Matters is a pan-specialty podcast for doctors, that discusses the most exciting, controversial, and practice-changing topics across medical practice as a whole. In our episodes, we’ll be talking to leading clinical experts, to researchers and funding institutes, and to industry partners about the well-known and perhaps the lesser-known issues affecting doctors in their clinics. We’ll be looking at everything from new drug approvals to social issues affecting medicine, and we’ll be challenging some of the status quo along the way.
Episodes
Episode 16: Sexual health in older age
Dr Holly Thomas helps us unpack the needlessly taboo subject of sex and sexual health in women of older age.
Episode 15: Breastfeeding after breast cancer
We talk to Dr. Cristina Saura about the concerns around breastfeeding after a breast cancer diagnosis, and why the POSITIVE results are such good news.
Episode 14: Diagnostic criteria for AD
Dr. Nicolas Villain outlines why it is so important to consider both clinical symptoms and biological findings when diagnosing Alzheimer's disease.
Episode 13: Advances in MASLD and MASH
Prof. Vlad Ratziu discusses the updated subclassification and nomenclature for steatotic liver disease, the therapeutic advance of resmetirom, and the future for MASLD and MASH.
Episode 12: Defining ARDS
Prof. Giacomo Grasselli takes us through the new concepts and explains why defining ARDS is such a difficult proposition.
Episode 11: Cardiac rehabilitation in patients with frailty
Dr. Eduard Shantsila discusses rehabilitation approaches for complex patients with heart disease and comorbid frailty, including those with cognitive vulnerability.
Episode 10: Disease-modifying therapy for type 1 diabetes
Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.
Episode 9: The gut microbiome and CAR T-cell therapy
Prof. Marion Subklewe explores the interplay between the gut microbiota and the efficacy and safety of CAR T-cell therapy in people with hematologic malignancies.
Episode 8: AI in stroke
Prof. Susanne Wegener discusses her team’s work to develop deep learning models that outperform neurologists in predicting patients’ clinical outcomes after stroke.
Episode 7: A deep dive into ADAURA
A conversation with Dr. Luis Paz-Ares about the key questions raised by the ADAURA trial of adjuvant osimertinib in early-stage NSCLC.
Episode 6: OCT for coronary imaging
Drs Niels Holm and Lene Andreasen explore the latest data on OCT and discuss its potential as an effective approach in PCI.
Episode 5: Next-generation sequencing
Professor Andrew Beggs discusses best practice in the use of next-generational sequencing within thyroid and non-small cell lung cancers. This content is intended only for healthcare providers and was made possible by educational funding provided by Illumina, Inc., and Eli Lilly and Company
Episode 4: Stem cell therapy for PD
Prof. Malin Parmar explains why stem cell therapy is such a good option for patients with Parkinson’s disease and how its safety is being tested in the STEM-PD trial.
Episode 3: Unravelling resistant hypertension
Professors Morris Brown and Bryan Williams join Jane Godsland to explore the theories behind resistant hypertension, and the latest treatment approaches.
Episode 2: Progress in PARP inhibitors
We speak to Dr. Elena Castro about the latest data on PARP inhibitors in prostate cancer as presented at this year's ASCO Genitourinary Cancers Symposium.
Episode 1: From Gray's to Google
We talk to Dr. Nathalie van Havre and Dr. Elsbeth Headley about ongoing medical education in the digital age.
Episode 0: Introducing Medicine Matters
Dr. Jane Godsland & Dr. Erik Heintz discuss the vision for Springer Medicine and offer some teasers for what's to come.